๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
To evaluate the efficacy and safety of Relmacabtagene Autoleucel in the tre...
Status
Not Yet Recruiting
Location
Beijing Cancer Hospital
Start Date
2023-12-28
Trial ID
NCT06142188
Treatments Being Tested
This is a single arm, open-label, dose escalation clinical study to evaluat...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2017-11-16
Trial ID
NCT03344367
Treatments Being Tested
The primary objective of this study is to estimate the efficacy of Relmacab...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2023-01-03
Trial ID
NCT05590221
Treatments Being Tested
This is a single arm, open-label, dose escalation clinical study to evaluat...
Status
Unknown
Location
Ruijin hospital
Start Date
2018-01-05
Trial ID
NCT03355859
Treatments Being Tested
This is a phase I, open-label, single-arm, multicenter study to assess the ...
Status
Completed
Location
Ruijin hospital
Start Date
2020-07-10
Trial ID
NCT04812691
Treatments Being Tested
This is a Phase I, open-label, single-arm, single center study to assess th...
Status
Withdrawn
Location
Jiangsu Province Hospital
Start Date
2022-02-28
Trial ID
NCT05259813
Treatments Being Tested
This is an open-label, single-arm study to treat the adult R/R Large B-cell...
Status
Unknown
Location
Tianjin Cancer Hospital
Start Date
2023-08-17
Trial ID
NCT06149169
Treatments Being Tested
To observe the efficacy and safety of a second infusion of relma-cel inject...
Status
Recruiting
Location
NO.197๏ผ Ruijin Er Road
Start Date
2023-05-01
Trial ID
NCT05806580
Treatments Being Tested
This is an open-label, single-arm study to treat the adult R/R Large B-cell...
Status
Recruiting
Location
Tianjin Cancer Hospital
Start Date
2024-08-15
Trial ID
NCT06479356
Treatments Being Tested
The primary objective of this study is to asess the efficacy of Relmacabtag...
Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Hospital
Start Date
2023-11-03
Trial ID
NCT06093841
Treatments Being Tested